Published on Autolus Therapeutics News Releases Autolus’s CAR‑T therapy, AUCATZYL (obecabtagene autoleucel), has received marketing...

Published by Regenerative Medicine Foundation The July 2025 Healthspan Compass newsletter showcases several advances in longevity and...

Dear Members, I hope this message finds you well. On behalf of the Sarawak Society for Cell and Gene Therapy Research (SSCTR), I am...

Published on Technology Networks A new study identifies TAF1 as a molecular switch that helps adult hematopoietic stem cells transition...

Published on Stanford Medicine News Stanford researchers have successfully used an antibody, briquilimab, to prepare children with...

Published in Cytotherapy Volume 27, Issue 4 A recent review in Cytotherapy highlights the ability of mesenchymal stromal cell (MSC)...

On 9 July 2025, I had the privilege of attending the Value-Based Healthcare (VBHC) Conference 2025, organized by the Pharmaceutical...

A new paper in Cytotherapy describes an integrated platform that may significantly accelerate how CAR-T cells are produced. Researchers...

Published on LinkedIn via Laurie Adami Laurie Adami shared her 7-year remission milestone after receiving Yescarta CAR‑T therapy in a...

Published on NIH Research Matters NIH-funded researchers led by Capstan Therapeutics and the University of Pennsylvania have devised a...

Published on Multiple Sclerosis News Today A systematic review published in Cureus highlights that mesenchymal stem cell (MSC) therapy is...

Published on Fierce Biotech A recent Jefferies report reveals that in Q1 2025, China-based biotechs accounted for 32 percent of global...

Published in Journal of Translational Medicine A new review highlights the potential of mesenchymal stem cell (MSC) therapies for...

Published in Journal of Translational Medicine A recent study explores how solid tumors alter CAR‑T cell lipid metabolism, affecting...

Published on LinkedIn via Spencer Knight CAR-T cell therapy, originally developed for cancer, is now advancing into non-oncological areas...

Published in Cytotherapy Volume 25, Issue 3 (March 2023) A recent review in Cytotherapy highlights how CRISPR-Cas9 gene editing is...

Published on LinkedIn via Spencer Knight AbbVie has announced a $2.1 billion acquisition of Capstan Therapeutics to deepen its investment...

Published on LinkedIn via Benjamin McLeod Recent research reviewed by Benjamin McLeod highlights significant progress in using immune...

Published on LinkedIn via Spencer Knight The FDA has updated CAR-T therapy regulations for BMS’ Abecma and Breyanzi, removing REMS...

Published on The Straits Times Singapore’s expanded newborn screening programme now includes severe combined immunodeficiency (SCID),...